These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 32233506)

  • 21. Determination of structural elements related to the biological activities of a potent decapeptide agonist of human C5a anaphylatoxin.
    Vogen SM; Prakash O; Kirnarsky L; Sanderson SD; Sherman SA
    J Pept Res; 1999 Jul; 54(1):74-84. PubMed ID: 10448972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular adjuvant effects of a conformationally biased agonist of human C5a anaphylatoxin.
    Tempero RM; Hollingsworth MA; Burdick MD; Finch AM; Taylor SM; Vogen SM; Morgan EL; Sanderson SD
    J Immunol; 1997 Feb; 158(3):1377-82. PubMed ID: 9013982
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decapeptide agonists of human C5a: the relationship between conformation and spasmogenic and platelet aggregatory activities.
    Sanderson SD; Kirnarsky L; Sherman SA; Ember JA; Finch AM; Taylor SM
    J Med Chem; 1994 Sep; 37(19):3171-80. PubMed ID: 7932541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of an antigen-specific CTL response by a conformationally biased agonist of human C5a anaphylatoxin as a molecular adjuvant.
    Ulrich JT; Cieplak W; Paczkowski NJ; Taylor SM; Sanderson SD
    J Immunol; 2000 May; 164(10):5492-8. PubMed ID: 10799917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential activities of decapeptide agonists of human C5a: the conformational effects of backbone N-methylation.
    Vogen SM; Paczkowski NJ; Kirnarsky L; Short A; Whitmore JB; Sherman SA; Taylor SM; Sanderson SD
    Int Immunopharmacol; 2001 Nov; 1(12):2151-62. PubMed ID: 11710544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Site-specific mutations in the N-terminal region of human C5a that affect interactions of C5a with the neutrophil C5a receptor.
    Carney DF; Hugli TE
    Protein Sci; 1993 Sep; 2(9):1391-9. PubMed ID: 8401225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Small molecular probes for G-protein-coupled C5a receptors: conformationally constrained antagonists derived from the C terminus of the human plasma protein C5a.
    Wong AK; Finch AM; Pierens GK; Craik DJ; Taylor SM; Fairlie DP
    J Med Chem; 1998 Aug; 41(18):3417-25. PubMed ID: 9719594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure-function studies in a series of carboxyl-terminal octapeptide analogues of anaphylatoxin C5a.
    Kawai M; Quincy DA; Lane B; Mollison KW; Or YS; Luly JR; Carter GW
    J Med Chem; 1992 Jan; 35(2):220-3. PubMed ID: 1732540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversal of hemodialysis granulocytopenia and pulmonary leukostasis: A clinical manifestation of selective down-regulation of granulocyte responses to C5adesarg.
    Skubitz KM; Craddock PR
    J Clin Invest; 1981 May; 67(5):1383-91. PubMed ID: 7229031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fifth complement cascade protein (C5) cleavage fragments disrupt the SDF-1/CXCR4 axis: further evidence that innate immunity orchestrates the mobilization of hematopoietic stem/progenitor cells.
    Jalili A; Shirvaikar N; Marquez-Curtis L; Qiu Y; Korol C; Lee H; Turner AR; Ratajczak MZ; Janowska-Wieczorek A
    Exp Hematol; 2010 Apr; 38(4):321-32. PubMed ID: 20153802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of response-selective agonists of human C5a anaphylatoxin: conformational, biological, and therapeutic considerations.
    Taylor SM; Sherman SA; Kirnarsky L; Sanderson SD
    Curr Med Chem; 2001 May; 8(6):675-84. PubMed ID: 11281848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of functionally selective C5aR2 ligands: novel modulators of C5a signalling.
    Croker DE; Monk PN; Halai R; Kaeslin G; Schofield Z; Wu MC; Clark RJ; Blaskovich MA; Morikis D; Floudas CA; Cooper MA; Woodruff TM
    Immunol Cell Biol; 2016 Sep; 94(8):787-95. PubMed ID: 27108698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TLR activation enhances C5a-induced pro-inflammatory responses by negatively modulating the second C5a receptor, C5L2.
    Raby AC; Holst B; Davies J; Colmont C; Laumonnier Y; Coles B; Shah S; Hall J; Topley N; Köhl J; Morgan BP; Labéta MO
    Eur J Immunol; 2011 Sep; 41(9):2741-52. PubMed ID: 21630250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary structure and functional characterization of rat C5a: an anaphylatoxin with unusually high potency.
    Cui L; Carney DF; Hugli TE
    Protein Sci; 1994 Aug; 3(8):1169-77. PubMed ID: 7987212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunosuppressive analogues of hexapeptide Tyr-Val-Pro-Leu-Phe-Pro, an immune system stimulant.
    Siemion IZ; Kubik A; Lisowski M; Szewczuk Z; Zimecki M; Wieczorek Z
    Int J Pept Protein Res; 1991 Jul; 38(1):54-61. PubMed ID: 1938105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The phosphatidylinositol 3-kinase signaling pathway exerts protective effects during sepsis by controlling C5a-mediated activation of innate immune functions.
    Wrann CD; Tabriz NA; Barkhausen T; Klos A; van Griensven M; Pape HC; Kendoff DO; Guo R; Ward PA; Krettek C; Riedemann NC
    J Immunol; 2007 May; 178(9):5940-8. PubMed ID: 17442978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of Potent and Selective Agonists for Complement C5a Receptor 1 with In Vivo Activity.
    Gorman DM; Li XX; Lee JD; Fung JN; Cui CS; Lee HS; Rolfe BE; Woodruff TM; Clark RJ
    J Med Chem; 2021 Nov; 64(22):16598-16608. PubMed ID: 34762432
    [TBL] [Abstract][Full Text] [Related]  

  • 38. C5a fragment of bovine complement. Purification, bioassays, amino-acid sequence and other structural studies.
    Gennaro R; Simonic T; Negri A; Mottola C; Secchi C; Ronchi S; Romeo D
    Eur J Biochem; 1986 Feb; 155(1):77-86. PubMed ID: 3081348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Encapsulation of an EP67-Conjugated CTL Peptide Vaccine in Nanoscale Biodegradable Particles Increases the Efficacy of Respiratory Immunization and Affects the Magnitude and Memory Subsets of Vaccine-Generated Mucosal and Systemic CD8
    Karuturi BVK; Tallapaka SB; Yeapuri P; Curran SM; Sanderson SD; Vetro JA
    Mol Pharm; 2017 May; 14(5):1469-1481. PubMed ID: 28319404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complement C5a-Induced Changes in Neutrophil Morphology During Inflammation.
    Denk S; Taylor RP; Wiegner R; Cook EM; Lindorfer MA; Pfeiffer K; Paschke S; Eiseler T; Weiss M; Barth E; Lambris JD; Kalbitz M; Martin T; Barth H; Messerer DAC; Gebhard F; Huber-Lang MS
    Scand J Immunol; 2017 Sep; 86(3):143-155. PubMed ID: 28671713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.